Introduction
Glycogen phosphorylase (GP) has been a validated target in combatting type 2 diabetes mellitus 1 (for a detailed foundation of inhibiting liver GP as an investigational concept for lowering blood glucose levels, please consult recent review articles [2] [3] [4] [5] [6] ). GP is a well-known enzyme that has been investigated by various methods as to its structural features and kinetic behaviour. 7, 8 By X-ray crystallographic studies on enzyme-inhibitor complexes several binding sites of GP have been discovered and are exploited for the design of new antidiabetic agents: the catalytic centre accom-60 modates mainly glucose derivatives and the inhibitor site binds aromatic compounds of various ring size and annelation type; classification of inhibitors binding to other sites such as the allosteric, the new allosteric, and the storage sites is more complex and can be found in the review literature. 5, 9 Among the glucose-based 10 inhibitors of GP, the first successful series was that of the glucosylamides [11] [12] [13] [14] (Chart 1a, A). Considering the NHCO moiety as a linker (i) between the sugar and the aromatic part of these compounds several molecules with bioisosteric replacements of the NHCO (see heterocyclic linkers ii-v) were 70 designed and synthesized. Kinetic and crystallographic studies showed a very high resemblance both in strength and structural features of binding between amides 1 and 2 and 1,2,3-triazoles à 3 and 4, respectively. 16, 17 Constitutional isomeric C-glucopyranosyl (Chart 1a, B) proved significantly better inhibitors than amides A with the same aglycon 5, 9 (compare inhibitor constants for 1 and 11 as well as 2 and 12, respectively). Based on the successful bioisos-
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teric modification of amides A we have started a program to synthesize a series of glucosyl heterocyclic compounds (Chart 1b) which can be derived from acyl ureas B by substituting each NHCO moiety by a heterocycle (linkers 1 and 2). In addition, compounds with a methylene group between linkers 1 and 2 lending higher flexibility to the molecules were also designed. In this paper we present our results in synthesizing 1,2,3-triazole and 1,2,4-oxadiazole linked derivatives of D-glucose. With the aim of targeting the inhibitor site of GP, compounds with aromatic rings in place of the glucosyl groups were also synthesized.
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2. Results and discussion
Syntheses
Access to suitable precursors to assemble the target oxadiazoles and triazoles is shown in Scheme 1. The O-perbenzoylated 5-b-Dglucopyranosyl tetrazole 17 was first prepared from 13 by the literature protocol 20 using in situ obtained ammonium azide in DMF at reflux (conditions a). To avoid chromatographic purification in larger scale preparations, two other methods were investigated, as well. Thus, reaction of 13 with Bu 3 SnN 3 in 1,2-dimethoxyethane at reflux (DME, conditions b) followed by acidic workup 21 gave 17 100 in essentially quantitative yield. Another method, applying Me 3-SiN 3 and Bu 2 SnO (conditions c) for in situ generation of dibutyl trimethylsilyloxytin azide 22 was similarly efficient. Conditions a afforded tetrazoles 18 and 20 from the corresponding nitriles 14 and 16 in good and excellent yields, respectively; however, reaction of 15 to give the 1-naphthyl derivative 19 failed. The reaction of 15 with Bu 3 SnN 3 in boiling DME (conditions b) needed three days to give 19, but using diglyme as a solvent of higher boiling temperature diminished the reaction time to two hours with a concomitant increase of the yield. 5-Substituted tetrazoles can be transformed into 1,3,4-oxadiazoles by acylation. 23, 24 Although acid chlorides are generally used in such acylations, 25 the chloride of propiolic acid is rather difficult to prepare and extremely sensitive to air. Therefore, the specific ethynyl-oxadiazoles 21-24 were prepared by DCC mediated reaction 26, 19 of propiolic acid with the corresponding tetrazoles 17-20 (conditions d) to give the target compounds in satisfactory yields. Chloroacetyl chloride under conditions e, on the other hand, furnished the chloromethyl-oxadiazoles 25 and 27 in excellent yields. Replacement of the chloride by azide was 120 effected by NaN 3 in DMF (conditions f) to give 26 or NaN 3 -18-crown-6 in acetone (conditions g) to produce 28 in very high yields. Ethynyl-oxadiazoles 21-24 were cyclized with several azides under variants of the copper(I) catalysed azide-alkyne cycloaddition (CuAAC) conditions [27] [28] [29] (Scheme 2). The triazole ring formation from 21 was similarly efficient by using phenyl azide (conditions a) or by in situ generation of this reagent from the corresponding commercial boronic acid 30 (conditions b) to give 29. (a 74%) 
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Enzyme inhibition studies
The kinetic parameters of the synthesized molecules were determined according to previously described enzymatic protocols 12, 38 and the results are summarized in Table 1 showing also the inhibitory efficiency of some reference compounds. Based on the verified bioisosteric replacement of NHCO by 1,2,3-triazole 180 for the glycogen phosphorylase case by enzyme kinetic and X-ray crystallographic investigations 16 (cf. Chart 1a, 1-4), the present study aimed at double replacement of the NHCONHCO moieties in acyl urea derivatives (compounds in entry 1) by two five membered heterocycles. Glucosyl-triazolyl-oxadiazoles (entry 2) proved significantly weaker inhibitors both in comparison to the acyl 
General procedure for the Zemplén deacylation
An O-peracylated compound (100 mg) was dissolved in dry MeOH (1 mL) and a solution of NaOMe (1 M in MeOH) was added to the solution in a catalytic amount. The reaction mixture was 250 kept at rt. When the reaction was complete (TLC, 7:3 CHCl 3 -MeOH) the solution was neutralized with a cation exchange resin Amberlyst 15 (H + form). Filtration and removal of the solvent resulted in the corresponding deacetylated sugar derivative, which, if necessary, was purified by column chromatography.
4.3.
General procedure for the synthesis of 5-substitutedtetrazoles by using Bu 3 SnN 3
A nitrile was dissolved in DME or diglyme and 3 equiv of Bu 3 SnN 3 were added. The mixture was stirred and heated at reflux for the given time while the reaction was monitored by TLC (4:1 260 PhCH 3 -EtOAc) to indicate completion of the transformation. Then it was cooled to rt and toluene and aq HCl (4 M solution) were added and the mixture was stirred for 2 h. The precipitated product was filtered, washed with water, and dried. The two phase filtrate was separated, the organic phase was diluted by hexane to precipitate a further crop of the product which was filtered and dried. The precipitated dicyclohexylurea (DCU) was filtered off and washed with dry toluene. The combined filtrate was added to a solution of a tetrazole 17-20 in dry toluene. This mixture was stirred at the given temperature. When the reaction was complete (TLC 1:1 EtOAc-hexane for 21, 10:1 PhCH 3 -MeOH for 22-24) the solvent was evaporated and the residue was purified by column chromatography (eluent PhCH 3 unless stated otherwise). 
2-Ethynyl-5-phenyl-1,3,4-oxadiazole (22)
Prepared by general procedure 4.4 from propiolic acid (3.81 g, 55 mmol), DCC (5.62 g, 27 mmol) in toluene (25 mL, than washing with 25 mL) and 18 (4.00 g, 27 mmol) in toluene (100 mL). Stirring Equimolar amounts of an alkyne and an azide were dissolved in CH 2 Cl 2 (7 mL/mmol alkyne). Water (the same volume as that of Q3 CH 2 Cl 2 ), CuSO 4 Á5H 2 O (5 mol %), L-ascorbic-acid (0.15 mol %) were added and the mixture was stirred at 50°C and monitored by TLC (1:1 EtOAc-hexane). After disappearance of the starting materials (aromatic azide: 2-3 h, glucosyl azide: overnight) the reaction was diluted with water and CH 2 Cl 2 , the phases were separated, and the aqueous layer was washed with CH 2 Cl 2 (2 Â 10 mL/mmol). The combined organic layer was dried, the solvent evaporated, and the residue purified by column chromatography. 4.5.2. In CH 2 Cl 2 -water mixtures with organic azides prepared in situ from boronic acids A boronic acid (1 equiv) and NaN 3 (1.2 equiv) were dissolved in
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MeOH (5 mL/mmol of boronic acid). CuSO 4 Á5H 2 O (0.1 equiv) was added and the mixture was stirred overnight. CH 2 Cl 2 and water (10 mL of each/mmol of boronic acid), an alkyne (0.3 equiv) and L-ascorbic acid (0.5 equiv) were added and the reaction mixture was heated to 50°C. After consumption of the alkyne (TLC 1:1 EtOAc-hexane) the reaction was diluted with water and CH 2 Cl 2 , the phases were separated and the aqueous layer was washed with CH 2 Cl 2 (2 Â 10 mL/mmol). The combined organic layer was dried, the solvent evaporated, and the residue purified by column chromatography. (ii) Prepared by general procedure 4.8.2 from PhN 3 (prepared in situ from phenylboronic acid (27 mg, 0.22 mmol)) and 21 for 480 2 h. Column chromatography (3:7 EtOAc-hexane) and crystallization from ethanol gave 29 (40 mg, 68%) as white crystals. 
2-(2
0 ,3 0 ,4 0 ,6 0 -Tetra-O-benzoyl-b-D-glucopyranosyl)-5-(1- phenyl-1,2,3-triazol-4-yl)-1,
2-(4-(5-Phenyl-1,3,4-oxadiazol-2-yl)-1H-1,2,3-triazol-1-yl)ethanol (34)
Prepared by general procedure 4.8. 
,4-oxadiazole (49) Oxadiazole 26 (100 mg, 0.14 mmol) was dissolved in CH 2 Cl 2 (2 mL) and water (2 mL), phenylacetylene (14 lL, 0.14 mmol), copper triflate (2 mg, 5.2 Â 10 À3 mmol) and copper dust (0.3 mg, 4.7 Â 10 À3 mmol) was added. The reaction mixture was heated at 40°C. After 24 h TLC (1:1 EtOAc-hexane) indicated completion of 780 the transformation. The reaction mixture was diluted with CH 2 Cl 2 (20 mL), the phases were separated, and the organic phase was washed with cold satd NaHCO 3 solution (3 Â 10 mL), water (10 mL), dried, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (1:1 EtOAc-hexane) to give 49 (56 mg, 70%, conversion 70%) as a colourless syrup. R f = 0. 35 
